Free Newsletter
Japanese scientist operates on lean budget
Shinya Yamanaka shook the stem cell research field with his work taking adult skin cells and turning them into embryonic stem cells. The key was identifying 24 genes that were the odds-on favorite for reprogramming the cell and then narrowing it to four that worked. In an interview with the Wall Street Journal, Yamanaka discusses how he operates a barebones lab on a million dollars a year, marveling at the billions of dollars that are spent in the U.S. Researchers in Japan, he says, are lone wolves. And he notes that ESC research is widely understood in the U.S., but barely registers on the Japanese psyche.
- read the report from The Wall Street Journal (sub. req.)
Related Article:
Adult stem cell prototype on the horizon. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: